ALAUNOS THERAPEUTICS INC (TCRT) Stock Price, Quote, News and Overview
NASDAQ:TCRT - Nasdaq - US98973P3091 - Common Stock - Currency: USD
TCRT Quote, Performance and Key Statistics
NASDAQ:TCRT (4/17/2025, 8:00:00 PM)
2.48
-0.19 (-7.12%)
The current stock price of TCRT is 2.48 USD. In the past month the price increased by 69.86%. In the past year, price decreased by -77.86%.
TCRT Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 17.09 | 306.02B | ||
| AMGN | AMGEN INC | 13.99 | 149.08B | ||
| GILD | GILEAD SCIENCES INC | 22.68 | 130.32B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1686.55 | 125.74B | ||
| REGN | REGENERON PHARMACEUTICALS | 12.34 | 61.56B | ||
| ARGX | ARGENX SE - ADR | 318.82 | 36.40B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 30.51B | ||
| ONC | BEIGENE LTD-ADR | N/A | 24.89B | ||
| BNTX | BIONTECH SE-ADR | N/A | 23.74B | ||
| NTRA | NATERA INC | N/A | 20.02B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 18.15B | ||
| BIIB | BIOGEN INC | 7.2 | 17.36B |
Related stock screener links
About TCRT
Company Profile
Alaunos Therapeutics, Inc. is a biopharmaceutical company and clinical-stage oncology-focused cell therapy company, which engages in the development of adoptive TCR engineered T-cell therapies, or TCR-T, designed to treat multiple solid tumor types in large cancer patient populations with unmet clinical needs. The company is headquartered in Houston, Texas and currently employs 1 full-time employees. The company went IPO on 2004-08-20. The firm is focused on exploring strategic alternatives, including, but not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. Separately, the Company is evaluating several potential in-licensing opportunities in obesity, oncology and virology.
Company Info
ALAUNOS THERAPEUTICS INC
2617 Bissonnet St, Suite 225
Houston TEXAS US
Employees: 1
Company Website: https://alaunos.com/
Investor Relations: https://ir.alaunos.com/
Phone: 13463554099
ALAUNOS THERAPEUTICS INC / TCRT FAQ
What is the stock price of ALAUNOS THERAPEUTICS INC today?
The current stock price of TCRT is 2.48 USD. The price decreased by -7.12% in the last trading session.
What is the ticker symbol for ALAUNOS THERAPEUTICS INC stock?
The exchange symbol of ALAUNOS THERAPEUTICS INC is TCRT and it is listed on the Nasdaq exchange.
On which exchange is TCRT stock listed?
TCRT stock is listed on the Nasdaq exchange.
What is ALAUNOS THERAPEUTICS INC worth?
ALAUNOS THERAPEUTICS INC (TCRT) has a market capitalization of 4.07M USD. This makes TCRT a Nano Cap stock.
How many employees does ALAUNOS THERAPEUTICS INC have?
ALAUNOS THERAPEUTICS INC (TCRT) currently has 1 employees.
What are the support and resistance levels for ALAUNOS THERAPEUTICS INC (TCRT) stock?
ALAUNOS THERAPEUTICS INC (TCRT) has a support level at 2.47 and a resistance level at 4.08. Check the full technical report for a detailed analysis of TCRT support and resistance levels.
Should I buy ALAUNOS THERAPEUTICS INC (TCRT) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of TCRT, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of TCRT, evaluating the profitability, health, valuation and growth aspects
- ALAUNOS THERAPEUTICS INC (TCRT) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- ALAUNOS THERAPEUTICS INC (TCRT) Sales and EPS estimates to see what analysts future expectations are.
- ALAUNOS THERAPEUTICS INC (TCRT) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- ALAUNOS THERAPEUTICS INC (TCRT) Insider and Institutional Ownership to learn about the owners and their transactions.
- ALAUNOS THERAPEUTICS INC (TCRT) Stock Chart to make your own analysis
- ALAUNOS THERAPEUTICS INC (TCRT) Latest news and press-releases to stay up to date.
Does ALAUNOS THERAPEUTICS INC (TCRT) stock pay dividends?
TCRT does not pay a dividend.
When does ALAUNOS THERAPEUTICS INC (TCRT) report earnings?
ALAUNOS THERAPEUTICS INC (TCRT) will report earnings on 2025-05-13.
What is the Price/Earnings (PE) ratio of ALAUNOS THERAPEUTICS INC (TCRT)?
ALAUNOS THERAPEUTICS INC (TCRT) does not have a PE ratio as the earnings reported over the last twelve months were negative (-1.98).
What is the Short Interest ratio of ALAUNOS THERAPEUTICS INC (TCRT) stock?
The outstanding short interest for ALAUNOS THERAPEUTICS INC (TCRT) is 4.28% of its float. Check the ownership tab for more information on the TCRT short interest.
TCRT Technical Analysis
ChartMill assigns a technical rating of 6 / 10 to TCRT. When comparing the yearly performance of all stocks, TCRT is a bad performer in the overall market: 74.89% of all stocks are doing better.
TCRT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to TCRT. TCRT has a great financial health rating, but its profitability evaluates not so good.
TCRT Financial Highlights
Over the last trailing twelve months TCRT reported a non-GAAP Earnings per Share(EPS) of -1.98. The EPS increased by 9.9% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -169.87% | ||
| ROE | -226.85% | ||
| Debt/Equity | 0 |
TCRT Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 43% to TCRT. The Buy consensus is the average rating of analysts ratings from 6 analysts.